Dihydroproscar
98%
- Product Code: 92893
Alias:
N-tert-butyl-3-oxo-4-aza-5Α-androst-17Β-carboxamide; F9 / FINASTERIDE INTERMEDIATE; F9(3-keto-4-aza-5Α-androst-17Β-tert Butanamide) (127,000 ); N-tert-butyl-3-oxo-4-aza-5alpha-androst-17beta-carboxamide; Dihydroposcar (finasteride intermediate); 3-Oxo- 4-aza-5α-androstane-17β-(N-t-butylcarboxamide);
CAS:
98319-24-5
| Molecular Weight: | 374.56 g./mol | Molecular Formula: | C₂₃H₃₈N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00214352 | |
| Melting Point: | Boiling Point: | 569.397ºC | |
| Density: | 1.051g/cm3 | Storage Condition: | -20°C |
Product Description:
Used primarily in the treatment of benign prostatic hyperplasia (BPH), it helps reduce the size of an enlarged prostate, alleviating symptoms such as difficulty in urination. It works by inhibiting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. Additionally, it is sometimes prescribed to lower the risk of urinary retention and the need for prostate surgery. It may also be used in combination with other medications for managing hair loss in men, as DHT is linked to male pattern baldness. Regular monitoring is advised to assess its effectiveness and manage potential side effects.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Solid |
| PURITY | 98-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿2,780.00 |
+
-
|
| 5.000 | 10-20 days | ฿8,980.00 |
+
-
|
Dihydroproscar
Used primarily in the treatment of benign prostatic hyperplasia (BPH), it helps reduce the size of an enlarged prostate, alleviating symptoms such as difficulty in urination. It works by inhibiting the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. Additionally, it is sometimes prescribed to lower the risk of urinary retention and the need for prostate surgery. It may also be used in combination with other medications for managing hair loss in men, as DHT is linked to male pattern baldness. Regular monitoring is advised to assess its effectiveness and manage potential side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :